Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus — StellaPhase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(5 sites)
South Africa
Synergy Biomed Research Institute, Durban, Eastern Cape Perinatal HIV Research Unit (PHRU), Johannesburg, Gauteng Wits Vaccines & Infectious Diseases Analytics (VIDA) Research Unit, Johannesburg, Gauteng SAMRC Chatworth CRS, Durban, KwaZulu-Natal SAMRC Isipingo CRS, Durban, KwaZulu-Natal Age range
1 Year – 45 Years
Last updated January 2026